Diseases of the Esophagus Instructions to Authors
Summary
Edited by: Neil Gupta and Giovanni Zaninotto
Online ISSN: 1442-2050
Frequency: 12 times a year, starting in 2017
Editorial Office: Sarah Wolper – dote.editorialoffice@jjeditorial.com
Diseases of the Esophagus is the official journal of the International Society for Diseases of the Esophagus (ISDE).
The Journal is devoted to esophageal diseases and covers all aspects of their etiology, diagnosis and both medical and surgical treatment. All manuscripts submitted to Diseases of the Esophagus must be original, i.e., not published elsewhere, except than in an abstract form, and should not be under consideration in another journal. Manuscripts must be prepared according the instructions below.
Editors-in-Chief invite submission of manuscripts in the following categories:
Original research at the highest level, including randomized controlled clinical studies, prospective case-controlled studies, retrospective case-controlled studies, substantive retrospective series
Systematic reviews and meta-analysis
Technology papers, describing new technologies and their evaluation
Practice Guidelines
Expert review articles (by invitation only)*
Editorials (by invitation only)*
Letters to the Editors
*Authors interested in submitting an Expert review article or an Editorial should contact one of the editors directly at g.zaninotto@imperial.ac.uk and ngupta713@gmail.com with their idea.
Basic sciences articles will no longer be considered for publication. Exceptions may be made if they possess a strong translational component and the Editors will contact authors directly with a decision of whether or not the paper will be reviewed. Diseases of the Esophagus does not accept Case Reports but under exceptional circumstances.
The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. All manuscripts are subject to peer review by at least two experts in the field, the Associate Editor, and the Editors-in-Chief. Final acceptance or rejection rests with the Editorial Board. The Editorial Board reserves the right to refuse any material for publication and advises that authors should retain copies of submitted manuscripts and correspondence, as material cannot be returned. The Editors-in-Chief strongly suggest that for those authors not of English-speaking countries, a revision of the English should be provided by a professional mother-tongue English-speaking scientific writer. The Editors-in-Chief take the right to send back to the authors every manuscript with poor English for proper editing before sending it to the reviewers. Reviewers are the most important asset of the Journal and their time should not be wasted.
Ethical Standards
Ethics
Authors should observe high standards with respect to publication ethics as set out by the Committee on Publication Ethics (COPE). Falsification or fabrication of data, plagiarism, including duplicate publication of the authors’ own work without proper citation, and misappropriation of the work are all unacceptable practices. Any cases of ethical misconduct are treated very seriously and will be dealt with in accordance with the COPE guidelines.
Authorship and Scientific Responsibility
Only those individuals who made direct contributions to the intellectual content of the paper may be listed as authors. Persons designated as authors should meet all of the following criteria:
Made substantial contributions to conception and design, and/or acquisition of data, and/or analysis and interpretation of data
Participated in drafting the article or revising it critically for important intellectual content
Gave final approval of the version to be submitted and any revised version to be published.
Within the Introduction Letter, the authors should describe the role of the study’s sponsors in the following areas:
Designing the study
Collecting, analyzing, and interpreting the data
Writing the report
Making the decision to submit for publication
After a manuscript is accepted for publication, no author can be removed from or added to the author list, nor can the order of the authors be changed without the written permission of all of the manuscript authors.
Informed Consent
The Journal adheres to the principles set forth in the Helsinki Declaration and holds that all reported research conducted with human participants should be conducted in accordance with such principles. Reports describing data obtained from research conducted in human participants must contain a statement in the Methods section indicating approval by the institutional review board and affirmation that informed consent was obtained from each participant. If patients are identifiable from illustrations, photographs, case reports, or other study data, release forms (or copies of the figures with the appropriate release statement) giving permission for publication must be submitted with the manuscript.
Article Types
Original articles: Should not exceed 4500 words, which includes all words submitted regardless of location within the manuscript. The counted words include title, abstract, text, acknowledgments, disclosures, tables, figure legends, and references. The combined total of illustrations and tables should not exceed 10 and the number of references should not exceed 40. At the discretion of the editor, supplementary material may be submitted for publication.
Systematic review and/or meta-analyses: Are limited to 6500 words, and all words are counted regardless of location within tables, figure legends and all references. Preferably, the total number of references should not exceed 80.
New technology: Articles are limited to 2500 words including title, abstract, text, acknowledgments, disclosures, tables figure legends, and references. The number of tables should not exceed three; the number of illustrations should not exceed five if tables are included, eight if there are no tables. The number of references should not exceed 10. All new technology papers require an acknowledgment, which discloses funding sources and includes a freedom of investigation statement.
Expert review articles: Are commissioned by the Editors on “hot topics” of esophageal physiology or disease. They should not exceed 4500 words with up to 20 references.
Editorials - Provide solicited commentary and analysis concerning an article in the issue of the Journal in which they appear. They may include one figure or table. Editorials are limited to 2500 words, with up to 10 references.
Correspondence/Letters to the Editors: The Editors welcome topical correspondence from readers relating to articles published in the Journal. Selected letters must be no more than 250 words in length, including no more than five references. When selected, these opinions will be sent to the authors of the related articles to be published with their response.
Effective with the 2012 volume, this journal began publishing in an online-only format.
Submission Checklist
Diseases of the Esophagus has a streamlined submission process designed to avoid unnecessary work. Manuscripts can be submitted in any common document format that can be easily opened and read by others. A single PDF or Word file is usually reliable. At first submission, it is not necessary to apply formatting to match house style. Instead, simply ask: would I enjoy reading and reviewing a manuscript formatted in this way? Some basic guidelines are provided below.
All manuscripts are submitted and reviewed via the journal's web-based manuscript submission system, https://mc.manuscriptcentral.com/des. New authors should create an account prior to submitting a manuscript for consideration. Questions about submitting to the journal should be sent to Sarah Wolper in the editorial office (dote.editorialoffice@jjeditorial.com).
Conflict of Interest
Oxford University Press requires declaration of any conflict of interest upon submission online. If the manuscript is published, conflict of interest information will be communicated in a statement in the published paper.
Language services
Manuscripts must be written in English. Spelling can be British or American, but consistent throughout. If you are not confident in the quality of your English, you may wish to use a language-editing service to ensure that editors and reviewers understand your paper. Language editing is optional and does not guarantee that your manuscript will be accepted, but it is strongly recommended. Edited manuscripts will still need to undergo peer review by the journal.
Cover letter
Papers are accepted for publication in the Journal on the understanding that the content has not been published or submitted for publication elsewhere. This must be stated in the covering letter. Authors must also state in the cover letter and in the manuscript that the protocol for the research project has been approved by a suitably constituted Ethics Committee of the institution within which the work was undertaken and that it conforms to the provisions of the Declaration of Helsinki in 1995 (as revised in Edinburgh 2000). All investigations on human subjects must include a statement that the subject gave informed consent and patient anonymity should be preserved. Authors should declare any financial support or relationships that may pose conflict of interest.
Basic formatting guide
Manuscript format, structure, and style
First Page
Please include:
Title of paper
Author names and affiliations, including country
Address and email of corresponding author
If there are multiple corresponding authors then nominate one for communication with the editorial office
Abstract The abstract should be structured in:
Background: a short paragraph describing the context for the study.
Methods: a statement of the plan and/or methods used in the study.
Results: a concise summary of findings.
Conclusions: a brief statement of what can be figured out from the study.
Maximum length of 250 words
No reference citations and avoid abbreviations
Authors
Please list all author contributions upon submission of the manuscript
Abbreviations
Please define abbreviations at the first occurrence
Tables & figures
Tables must be in an editable format (eg, Word).
Figures and text may be submitted in one file rather than separate files
Should be accompanied by a legend
Please number figures and tables consecutively
Figures should use a common image format (e.g. pdf, eps, gif, tif, jpg)
Further information on figures can be found here
For any further queries, email dote.editorialoffice@jjeditorial.com
Videos
This journal accepts videos to be published either as figures or as supplementary material
Videos should be submitted in MP4 format, if possible
All videos should have an accompanying legend and/or audio comment
References
May be formatted in any readable style at submission
Authors are responsible for their accuracy
Later, authors may be asked to comply with the journal’s citation convention (eg, Zotero/Mendeley/EndNote)
Acknowledgements/funding details
These should be included at the end of the text
Please refer to your funding organizations to acknowledge their support
PubMed Central links will require a specific grant number to be referenced
Supplementary data
Material to be considered as Supplementary Material should be submitted at the same time as the main manuscript
Supplementary material should be referred to in the main manuscript at an appropriate point in the text
Supplementary material will be available online only and will not be copyedited, so ensure that it is clearly and succinctly presented
The style should conform with the rest of the paper
The presentation should work on any internet browser
We recommend that files are no more than 2MB each, although exceptions can be made at the editorial office’s discretion
After initial review, you may be asked to supply editable files that match journal formatting requirements, and high-resolution figures. For more details, please consult the journal's style guide below.
Reporting Clinical Trials / Standards
Registration of Clinical Trials
The Editors require the preregistration of all prospective clinical trials that have a control group, as well as any commercially-sponsored clinical trial, including Phase I and II trials. Preregistration of meta-analysis and systematic reviews is not mandatory, but it is strongly recommended. Registration for retrospective reviews or summaries of standard clinical treatment is not required. Relevant trials must have a unique study number assigned at www.clinicaltrials.gov, the principle site of registration sponsored by the National Library of Medicine (NLM). Detailed directions and a tutorial for registering a trial are available at http://prsinfo.clinicaltrials.gov
Reporting Standards
We are asking authors to use the following reporting guideline checklists when drafting and submitting their manuscripts. Once you have completed this checklist, please save a copy and upload it as part of your submission. When requested to do so as part of the upload process, please select the file type: Reporting Guidelines Checklist. Please DO NOT include this checklist as part of the main manuscript document. It must be uploaded as a separate file.
Randomized Controlled Trials: Authors reporting the results of randomized controlled trials must submit a CONSORT checklist and flow diagram available at: http://www.consort-statement.org. Authors must also provide a flow diagram as Figure 1 of the submitted manuscript. Authors of uncontrolled, pilot trials are not required to complete the CONSORT checklist or flow diagram.
Observational Studies: Require the STROBE checklists for cohort, case-controlled, and cross-sectional studies and all observational studies of human subjects as well as case series, pilot studies, and retrospective data collection studies. Please make note on this checklist http://www.equator-network.org/wp-content/uploads/2013/09/STROBE-Checklist-v4-MS-Word.doc which page numbers of the manuscript include the requested information.
Systematic Review or Meta-analyses: Authors reporting systematic review or meta-analysis of randomized trials must submit the PRISMA (previously named QUOROM) statement, which is available at: http://www.equator-network.org/reporting-guidelines/prisma Authors using the PRISMA checklist should also include a PRISMA flow diagram as Figure 1 of the submitted manuscript.
Interventional Effectiveness Studies: Authors reporting studies of the efficacy of various interventions must submit the completed SQUIRE checklist. The checklist and glossary of key terms used in SQUIRE 2.0 is available at: http://www.equator-network.org/wp-content/uploads/2012/12/SQUIRE-2.0-checklist.pdf
Diagnostic Accuracy: Authors reporting studies of the accuracy of diagnostic tests should provide the completed STARD checklist. Authors must also provide a flow diagram as Figure 1 of the submitted manuscript. The STARD checklist is available at: http://www.equator-network.org/wp-content/uploads/2015/03/STARD-2015-checklist.pdf
Qualitative Research: Authors submitting studies using qualitative methods should include the SRQR (formally known as COREQ) checklist as part of their submission to the journal.
Consultant Statistician and Statistical Methods
All manuscripts with statistical analysis are required to undergo biostatistical review to ensure adequate and appropriate study design, analysis, interpretation, and reporting. The Journal requires that a biostatistician review these manuscripts prior to submission.
Manuscript Processing and Peer Review
Upon submission, the manuscript is checked for compliance with these author instructions. If the submission is complete, the Editors-in-Chief assess the manuscript for suitability. A small percentage of manuscripts are rejected without peer review—for example, if the article type is inappropriate, if the subject matter is unsuitable for the readership, or if the scientific and/or surgical merit of the paper is flawed (not ethical). All other articles are allocated to a specialist Associate Editor, who either selects relevant referees for single-blind peer review (the referees know the identity of the authors, but the authors do not know the identity of the referees) or consults with at least one other Editor before rejecting the manuscript without peer review (for the reasons outlined above).
Two or three referees are usually invited to comment on each submission. If the first two referee reports are in agreement, a decision is made on the basis of two reports, hopefully saving the third referee valuable time. When the opinions of the referees differ significantly, the manuscript is discussed at the Editors’ meeting. When a decision has been reached, this is communicated to the author. Articles not subjected to peer review include solicited Expert Reviews and Editorials (in which case the topic and structure of the article is largely designed by the Editor-in-Chief in collaboration with the author) and the Correspondence section. These are all managed with the highest standards by the Diseases of the Esophagus Editors.
The Editors’ decision is final unless there is a proven error in the process of manuscript evaluation or peer review. If you believe that there has been an error of process in the handling of your manuscript, please address your concerns to the Editor-in-Chief and include the manuscript submission number.
For more information on the journal’s review process or a manuscript’s progress, please contact the editorial office at dote.editorialoffice@jjeditorial.com.
Rapid Review
Diseases of the Esophagus now offers a rapid review of manuscripts previously submitted to another journal.
As stated in the “Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals” ( http://www.icmje.org ; Updated December 2019): “If the manuscript has been submitted previously to another journal, it is helpful to include the previous editor’s and reviewers’ comments with the submitted manuscript, along with the authors’ responses to those comments. Editors encourage authors to submit these previous communications and doing so may expedite the review process.”
For manuscripts previously submitted to other journals with impact factor more than 5, if authors upload previous editor’s and reviewers’ comments along with their responses to their electronic submission, Diseases of the Esophagus will guarantee a rapid (within 5 business days) in-house assessment once the manuscript has been processed (after the completion of the submission checklist), with three possible outcomes:
Acceptance or acceptance with minor changes (no additional external reviews needed)
Rejection
Additional external review needed; in this case the authors will have the possibility of accepting the additional external review or withdrawing the manuscript
If you can comply with the above requirements, check the box that states, “I have previously submitted this paper to another journal with Impact Factor of 5 or higher, and I would like it to be considered under the Rapid Review policy.” This checkbox is located in Step 5 of the submission process.
Post-Acceptance Formatting
Manuscript Preparation
Submissions should be doubled-spaced in Microsoft Word using US letter (8.5 by 11 inch / 216 by 279 mm) sizing. The top, bottom and side margins should be 30 mm. All pages should be numbered consecutively in the top right-hand corner, beginning with the title page. Indent new paragraphs. Turn the hyphenation option off, including only those hyphens that are essential to the meaning. The font should be 12 point. Upon revision papers should be submitted in an editable file format (i.e., not PDF) and figures should be submitted as separate, high-resolution, files. For information on Latex files, please see the Latex section (https://academic.oup.com/journals/pages/authors/preparing_your_manuscript).
Style
Manuscripts should follow the style of the AMA Manual of Style: A Guide for Authors and Editors (Oxford University Press, New York).
All measurements must be given in SI units as outlined in the latest edition of Units, Symbols and Abbreviations: A Guide for Medical and Scientific Editors and Authors (Royal Society of Medicine Press, London).
Abbreviations should be used sparingly and only where they ease the reader’s task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation. At the first mention of a chemical substance, give the generic name only. Trade names should not be used. Drugs should be referred to by their generic names, rather than brand names.
Parts of the manuscript
Manuscripts should be presented in the following order: (i) title page, (ii) abstract and key words, (iii) text, (iv) acknowledgments, (v) references, (vi) figure legends, (vii) tables (each table complete with title and footnotes), and (viii) figures. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.
Title page
The title page should contain (i) the title of the paper, (ii) the full names of the authors, and (iii) the addresses of the institutions at which the work was carried out together with (iv) the full postal and email address, plus facsimile and telephone numbers, of the author to whom correspondence about the manuscript, proofs and requests for offprints should be sent.
In keeping with the latest guidelines of the International Committee of Medical Journal Editors, each author’s contribution to the paper is to be quantified.
The title should be short, informative and contain the major key words. A short running title (fewer than 40 characters, including spaces) should also be provided.
Abstract and key words
Articles must have a structured abstract that summarize the data contained in the manuscript in an easily understood presentation of about 250 words.
The format should consist of:
Background: a short paragraph describing the context for the study.
Methods: a statement of the plan and/or methods used in the study.
Results: a concise summary of findings.
Conclusions: a brief statement of what can be figured out from the study.
The abstract should not contain abbreviations or references. Up to five key words should be supplied below the abstract and should be taken from those recommended by the Index Medicus Medical Subject Heading (MeSH) browser list (http://www.nlm.nih.gov/mesh/meshhome.html).
Text
Authors should use subheadings to divide the sections of their manuscript: Introduction, Methods, Results, Discussion, Acknowledgments, References.
Acknowledgments
The source of financial grants and other funding should be acknowledged, including a frank declaration of the authors’ industrial links and affiliations. The contribution of colleagues or institutions should also be acknowledged. Thanks to anonymous reviewers are not appropriate.
……
更多详情：
https://academic.oup.com/dote/pages/Author_Guidelines
